Skip to content
Search

Latest Stories

Submit Guest Post

India's coronavirus death toll hits 20,000 as infections surge

INDIA's death toll from the coronavirus pandemic surpassed 20,000 on Tuesday (7) and case numbers surged as the south Asian nation pushed ahead with relaxations to its almost two-month lockdown amid grim economic forecasts.

The rate of both new virus infections and deaths are rising at the fastest pace in three months, as officials lift a vast lockdown of India's 1.3 billion people that has left tens of thousands without work and shuttered businesses.


The country reported 467 new deaths on Tuesday, taking the toll to 20,160. It also recorded 22,252 new infections, increasing the total to 719,665. India on Monday (6) overtook Russia as the third most affected country globally, behind the US and Brazil.

But its death rate per 10,000 people is still a low 0.15, compared with 3.97 in the US and 6.65 in the UK, according to a Reuters tally.

Health officials fear the number of deaths, which usually lag behind the detection of new infections, could rise significantly in coming weeks. India's death toll is currently the world's seventh highest, behind the US, Brazil, the UK, Italy, France and Spain.

Over the first week of July, India reported an average of 450 deaths each day, compared with 250 in the first week of June, and 101 in the first week of May.

Officials on Monday withdrew a planned reopening of the Taj Mahal, citing the risk of new coronavirus infections spreading in the northern city of Agra from visitors flocking to see the 17th century monument to love.

The reopening of the Indian economy has been sporadic. While domestic travel has been opened up, international flights remain suspended and containment zones, areas identified as most affected by the virus, remain under strict lockdown.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weight loss pill

Foundayo is the latest GLP-1 treatment to receive UK approval in tablet form

Representational image: iStock

UK becomes first European nation to approve new weight-loss pill, but NHS access is still pending

  • The UK is the first European country to approve Eli Lilly’s Foundayo pill.
  • The tablet is taken once a day without food or water restrictions.
  • NHS availability will depend on a separate NICE assessment.

The UK has become the first European nation to approve a new daily weight-loss pill, giving patients another option beyond the injectable treatments that have dominated the GLP-1 market.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s orforglipron, sold under the brand name Foundayo, on August 10 for weight management and to improve blood sugar control in adults with type 2 diabetes.

Keep ReadingShow less